• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges in the Design and Interpretation of Noninferiority Trials.

作者信息

Mauri Laura, D'Agostino Ralph B

机构信息

From the Division of Cardiovascular Medicine, Brigham and Women's Hospital (L.M.), Harvard Medical School (L.M.), the Department of Mathematics and Statistics, Boston University (R.B.D.), and Baim Institute for Clinical Research (L.M., R.B.D.) - all in Boston.

出版信息

N Engl J Med. 2017 Oct 5;377(14):1357-1367. doi: 10.1056/NEJMra1510063.

DOI:10.1056/NEJMra1510063
PMID:28976859
Abstract
摘要

相似文献

1
Challenges in the Design and Interpretation of Noninferiority Trials.非劣效性试验设计与解读中的挑战。
N Engl J Med. 2017 Oct 5;377(14):1357-1367. doi: 10.1056/NEJMra1510063.
2
Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.非劣效性药物试验未能报告足够的方法学细节：对2010年至2015年非劣效性试验的评估。
J Clin Epidemiol. 2019 Apr;108:144-146. doi: 10.1016/j.jclinepi.2018.11.028. Epub 2018 Dec 6.
3
Interpretation and inference in noninferiority randomized controlled trials in drug research.药物研究中非劣效性随机对照试验的解释和推断。
Clin Pharmacol Ther. 2010 Sep;88(3):420-3. doi: 10.1038/clpt.2010.134. Epub 2010 Jul 28.
4
Commentary: Systematic reviewers face challenges from varied study designs.评论：系统评价者面临来自各种研究设计的挑战。
BMJ. 2002 Aug 31;325(7362):461.
5
An orwellian discourse on the meaning and measurement of noninferiority.关于非劣效性的意义与衡量的奥威尔式论述。
Am J Cardiol. 2007 Jan 15;99(2):284-7. doi: 10.1016/j.amjcard.2006.07.090. Epub 2006 Nov 27.
6
Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.慢性病随机临床试验的局限性：解释与建议。
Adv Mind Body Med. 2002 Winter;18(2):14-21.
7
A bootstrap-based test for establishing noninferiority in clinical trials.一种基于自抽样法的用于在临床试验中确立非劣效性的检验方法。
J Biopharm Stat. 2006 May;16(3):357-63. doi: 10.1080/10543400600609478.
8
Randomization as a basis for inference in noninferiority trials.随机化作为非劣效性试验推断的基础。
Pharm Stat. 2006 Oct-Dec;5(4):265-71. doi: 10.1002/pst.214.
9
Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.理解非劣效性：从临床和统计学角度看其在心血管临床试验中的应用
Prog Cardiovasc Dis. 2007 Jan-Feb;49(4):284-99. doi: 10.1016/j.pcad.2006.10.001.
10
Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.现行推荐用于非劣效试验设计和解释的经验后果。
J Gen Intern Med. 2018 Jan;33(1):88-96. doi: 10.1007/s11606-017-4161-4. Epub 2017 Sep 5.

引用本文的文献

1
Tackling control risk problems in non-inferiority trials.解决非劣效性试验中的对照风险问题。
BMJ Med. 2025 Jun 15;4(1):e000845. doi: 10.1136/bmjmed-2023-000845. eCollection 2025.
2
Correspondence on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study' by Smeenk .关于Smeenk的《帕博利珠单抗混合给药方案在晚期非小细胞肺癌中不劣于固定剂量给药：一项真实世界、回顾性双中心队列研究》的通信
J Immunother Cancer. 2025 Jul 22;13(7):e011895. doi: 10.1136/jitc-2025-011895.
3
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data.
缩短曲妥珠单抗辅助治疗HER2阳性乳腺癌患者的疗程：一项纳入个体患者数据的随机对照非劣效性试验的荟萃分析
BMJ Oncol. 2025 Jun 20;4(1):e000810. doi: 10.1136/bmjonc-2025-000810. eCollection 2025.
4
Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction: a study protocol for the Stop OsteoARthritis (SOAR) randomized controlled trial.数字教育与运动疗法对比前交叉韧带重建术后早发性膝骨关节炎高危年轻人的最小干预：停止骨关节炎（SOAR）随机对照试验的研究方案
Trials. 2025 Jun 20;26(1):213. doi: 10.1186/s13063-025-08896-6.
5
Comparison of medical history documentation efficiency and quality based on GPT-4o: a study on the comparison between residents and artificial intelligence.基于GPT-4o的病史记录效率与质量比较：住院医师与人工智能的比较研究
Front Med (Lausanne). 2025 May 14;12:1545730. doi: 10.3389/fmed.2025.1545730. eCollection 2025.
6
Fentanyl or esketamine for traumatic pain (FORE-PAIN) trial: study protocol for a double-blind multi-arm randomized non-inferiority trial.芬太尼或艾司氯胺酮用于创伤性疼痛（FORE-PAIN）试验：一项双盲多臂随机非劣效性试验的研究方案
Trials. 2025 May 26;26(1):172. doi: 10.1186/s13063-025-08869-9.
7
Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of power.具有事件发生时间结局的非劣效性临床试验中的汇总指标：效能的实证比较
BMC Med Res Methodol. 2025 May 24;25(1):139. doi: 10.1186/s12874-025-02576-4.
8
European Stroke Organisation (ESO) guideline on aphasia rehabilitation.欧洲卒中组织（ESO）失语症康复指南。
Eur Stroke J. 2025 May 22:23969873241311025. doi: 10.1177/23969873241311025.
9
Therapeutic challenges and new therapeutic targets for combined capillary pulmonary hypertension: a review.联合性毛细血管前性肺动脉高压的治疗挑战与新治疗靶点：综述
Front Med (Lausanne). 2025 May 2;12:1579112. doi: 10.3389/fmed.2025.1579112. eCollection 2025.
10
Non-inferiority trials in clinical ophthalmology: a systematic review.临床眼科非劣效性试验：一项系统评价
Eye (Lond). 2025 May 1. doi: 10.1038/s41433-025-03819-w.